The latest, most comprehensive ovarian rejuvenation program developed by professor Aleksandar Ljubić.Dual Stem cell Activation (DSA) involves the simultaneous application of two types ofautologous stem cells (SC) – mesenchymal and hematopoietic SC, derived from bonemarrow and peripheral blood.
The capacity of SC for differentiation, immunomodulation, and angiogenesis renders them potent therapeutic agents in the field of regenerative reproductive medicine.
DSA therapy results in the improvement of hormonal levels, reducing inflammation andoxidative stress, with follicular activation, angiogenesis, and functional restoration of the ovary, and improving endometrial receptivity.
The fundamental principle of DSA is the simultaneous application of two types of stemcells, mesenchymal and hematopoietic, providing synergy and increasing the effects ofindividual cell types.
DSA enables the obtaining of a significantly larger number of SCs with the possibility of cryopreservation and later enhancement of the positive effects oftherapy.
Learn more about the breaking new technology within the ovarian rejuvenation, created by professor Aleksandar Ljubić:
